dilaudid hydromorphone hydrochloride liquid dilaudid hydromorphone hydrochloride tablet
1 INDICATIONS AND USAGE DILAUDID Oral Solution and DILAUDID Tablets are indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. Limitations of Use Because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses [see Warnings and Precautions ( 5.2 )] , reserve DILAUDID Oral Solution and DILAUDID Tablets for use in patients for whom alternative treatment options [e.g., non-opioid analgesics or opioid combination products]: Have not been tolerated, or are not expectedto be tolerated, Have not provided adequate analgesia, or are not expected to provide adequate analgesia DILAUDID Oral Solution and DILAUDID Tablets contain hydromorphone, an opioid agonist, and are indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. ( 1 ) Limitations of Use ( 1 ) Because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses, reserve DILAUDID Oral Solution or DILAUDID Tablets for use in patients for whom alternative treatment options [e.g., non-opioid analgesics or opioid combination products]: Have not been tolerated, or are not expected to be tolerated, Have not provided adequate analgesia, or are not expected to provide adequate analgesia
purdue pharma lp
TRIANGLE WHITE P d 8
P d 8 TRIANGLE WHITE
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING Protect from light. DILAUDID Oral Solution is a a clear, colorless to pale yellow, slightly viscous liquid. It is available in: Bottles of 1 pint (473 mL) – NDC# 59011-451-01. DILAUDID 2 mg Tablets are light orange, round, flat-faced tablets, with beveled edges, debossed with a “P” on one side and the number “2” on the opposite side. They are available in: Bottles of 100 - NDC # 59011-452-10 Unit Dose Packages of 100 (4x25) - NDC # 59011-452-01 DILAUDID 4 mg Tablets are light yellow, round, flat-faced tablets, with beveled edges, debossed with a “P” on one side and the number “4” on the opposite side. They are available in: Bottles of 100 - NDC # 59011-454-10 Unit Dose Packages of 100 (4x25) - NDC # 59011-454-01 Bottles of 500 - NDC # 59011-454-05 DILAUDID 8 mg Tablets are white, triangular shaped tablets debossed with a “P” and an inverted “P” separated with a bisect on one side of the tablet and debossed with the number “8” on the other side of the tablet. They are available in: Bottles of 100 - NDC# 59011-458-10 Store at 25°C (77°F); excursions permitted to 15°-30°C (59°-86°F). [See USP Controlled Room Temperature].
More pills like TRIANGLE P d 8